Evidence map›Paper›PMID 32937175›Full record

ReviewEnvironmental research2020

Biomarkers of metabolic disorders and neurobehavioral diseases in a PCB- exposed population: What we learned and the implications for future research.

Jyothirmai J Simhadri, Christopher A Loffredo, Tomas Trnovec, Lubica Palkovicova Murinova, Gail Nunlee-Bland, Janna G Koppe, Greet Schoeters, Siddhartha Sankar Jana, Somiranjan Ghosh

Open access · greenAbstract readReview
In one paragraph

Review in Environmental research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 5 countries.

Jyothirmai J SimhadriDepartment of Pediatrics and Child Health, College of Medicine, Howard University, Washington DC, USA.
Christopher A LoffredoDepartments of Oncology and of Biostatistics, Georgetown University, Washington, DC, USA.
Tomas TrnovecDepartment of Pediatrics, EKZ-AMC, University of Amsterdam, Netherlands.
Lubica Palkovicova MurinovaDepartment of Environmental Medicine, Slovak Medical University, Bratislava, Slovak Republic.
Gail Nunlee-BlandDepartment of Pediatrics and Child Health, College of Medicine, Howard University, Washington DC, USA.
Janna G KoppeDepartment of Pediatrics, EKZ-AMC, University of Amsterdam, Netherlands.
Greet SchoetersDept. Biomedical Sciences, University of Antwerp, Antwerp, Belgium & Flemish Institute for Technological Research (VITO), Mol, Belgium.
Siddhartha Sankar JanaIndian Association for the Cultivation of Science, Kolkata, India.
Somiranjan GhoshDepartment of Pediatrics and Child Health, College of Medicine, Howard University, Washington DC, USA; Department of Biology, Howard University, Washington, DC, USA. Electronic address: sghosh@howard.edu.
Howard University · USUniversity of Amsterdam · NLGeorgetown University · USIndian Association for the Cultivation of Science · INSlovak Medical University · SKUniversity of Antwerp · BE

Funding

Sleep Disorders in Adults with Sickle Cell Disease: Frequency, Associations with Cardiovascular and Pain Indicators, and Responses to TreatmentU54MD007597 · NIMHD · HOWARD UNIVERSITY · PI GEORGES E. HADDAD · 2019 to 2026
$37.7M
Fatty Liver Disease in African AmericansP20CA242617 · NCI · HOWARD UNIVERSITY · PI TAYLOR, TELETIA RENEE · 2019 to 2022
$1.2M
Fatty Liver Disease in African AmericansP20CA242611 · NCI · GEORGETOWN UNIVERSITY · PI ADAMS-CAMPBELL, LUCILE LAUREN, TAYLOR, TELETIA RENEE · 2019 to 2022
$868k
PCBs and Otodevelopment in Eastern SlovakiaR03TW007152 · FIC · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HERTZ-PICCIOTTO, IRVA · 2006 to 2008
$100k
FIC NIH HHS R03 TW007152NCI NIH HHS P20 CA242611NCI NIH HHS P20 CA242617NIMHD NIH HHS U54 MD007597
6 · The paper itself

Abstract

Polychlorinated biphenyls (PCBs) are one of the original twelve classes of toxic chemicals covered by the Stockholm Convention on Persistent Organic Pollutants (POP), an international environmental treaty signed in 2001. PCBs are present in the environment as mixtures of multiple isomers at different degree of chlorination. These compounds are manmade and possess useful industrial properties including extreme longevity under harsh conditions, heat absorbance, and the ability to form an oily liquid at room temperature that is useful for electrical utilities and in other industrial applications. They have been widely used for a wide range of industrial purposes over the decades. Despite a ban in production in 1979 in the US and many other countries, they remain persistent and ubiquitous in environment as contaminants due to their improper disposal. Humans, independent of where they live, are therefore exposed to PCBs, which are routinely found in random surveys of human and animal tissues. The prolonged exposures to PCBs have been associated with the development of different diseases and disorders, and they are classified as endocrine disruptors. Due to its ability to interact with thyroid hormone, metabolism and function, they are thought to be implicated in the global rise of obesity diabetes, and their potential toxicity for neurodevelopment and disorders, an example of gene by environmental interaction (GxE). The current review is primarily intended to summarize the evidence for the association of PCB exposures with increased risks for metabolic dysfunctions and neurobehavioral disorders. In particular, we present evidence of gene expression alterations in PCB-exposed populations to construct the underlying pathways that may lead to those diseases and disorders in course of life. We conclude the review with future perspectives on biomarker-based research to identify susceptible individuals and populations.

Indexed as

Environmental PollutantsMetabolic DiseasesPolychlorinated BiphenylsAnimalsBiomarkersHalogenationHumansBiomarkersEnvironmental PollutantsPolychlorinated BiphenylsBiomarkersExposureGene expressionGene validationPolychlorinated biphenyls (PCBs)

Identifiers

PMID32937175
PMCPMC7658018
OpenAlexW3086730844

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.